AIIC
KZR

AJU IB Investment Company’s Kezar Life Sciences KZR Stock Holding History

AJU IB Investment Company’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,892
Closed -$1.11M – 10
2021
Q3 		$1.11M Hold
12,892
– – 0.72% 9
2021
Q2 		$700K Hold
12,892
– – 0.4% 9
2021
Q1 		$768K Hold
12,892
– – 0.29% 9
2020
Q4 		$673K Buy
+12,892
New +$717K 0.25% 9

Other funds holding KZR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

AJU IB Investment Company's KZR Position: Q4 2021 in Review

AJU IB Investment Company sold out of Kezar Life Sciences (KZR) in Q4 2021, closing a stake of 12,892 shares — an estimated $1.11M sold.

AJU IB Investment Company first reported a position in KZR in Q4 2020 and held it in 4 quarters. The position peaked at $1.11M in Q3 2021. 107 funds tracked by Wall St. Rank hold KZR as of Q4 2021.

  • AJU IB Investment Company reported no remaining Kezar Life Sciences position as of Q4 2021 after selling out during the quarter.
  • AJU IB Investment Company sold 12,892 Kezar Life Sciences shares in Q4 2021, an estimated $1.11M.
  • AJU IB Investment Company first reported a position in Kezar Life Sciences in Q4 2020 and held it in 4 quarters.
  • AJU IB Investment Company's Kezar Life Sciences position peaked at $1.11M in Q3 2021.
  • 107 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2021.

Based on AJU IB Investment Company's 13F filing for Q4 2021, filed 9 Feb 2022.